The firm had posted a net loss of Rs 0.57 crore in the year-ago period, it said in a BSE filing.
Total income from operations rose to Rs 750.92 crore in the October-December quarter this fiscal from Rs 728.29 crore during the same quarter in 2015-16.
JK Lakshmi Cement said, "Despite dent in demand due to demonetisation, company grew its production and sales largely on account of stabilisation of Drug plant this year".
"The company is enhancing its Drug capacity from 1.8 million tons to 2.7 million tons which is likely to completed by March. The company's project in its subsidiary company UCWL is near completion and likely to be operational by March. With these company's total capacity including UCWL will stand increased to 12.5 million tonnes by the end of this fiscal year," JK Lakshmi said in a release.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
